In a recent decision, the U.S. Court of Appeals for the Fifth Circuit reaffirmed a familiar — but increasingly debated — principle in employment discrimination law: Plaintiffs proceeding under the ...

COST reports Q3 earnings tonight after a roughly 7% weekly slide, needing strong results to justify its 47x forward earnings valuation. Wall Street expects Q3 EPS of $4.92 and ~$66B in revenue, while ...

Gap issued mixed fiscal first-quarter results, missing on the top line but beating on the bottom. CEO Richard Dickson told CNBC sales at Old Navy were worse than expected after the brand's spring and ...

Dick's Sporting Goods is putting in the hard work to turn around Foot Locker, which returned to growth during the fiscal first quarter for the first time since the end of the 2024. Still, that hard ...

ORLANDO, Fla. — Amikacin liposome inhalation suspension (ALIS) is already FDA approved to treat people with treatment-refractory Mycobacterium avium complex (MAC) lung disease, and newly announced ...

NBC Sports Averages 4.9 Million Viewers for 13 NBA Playoff Games on NBC and Peacock from April 19-28, the Most-Watched for Comparable Windows Since 1996 Celtics-76ers on Sunday, April 26, Delivers ...

Synthetic semaglutide provides glycemic control and weight reduction comparable to branded Ozempic in patients with type 2 diabetes. A new synthetic semaglutide injection made by Sun Pharma, compared ...

Researchers conducted a phase 3 trial to compare the efficacy and safety of synthetic semaglutide with Ozempic® for glycemic control. Synthetic semaglutide provides glycemic control and weight ...

Researchers conducted a phase 3 trial to compare the efficacy and safety of synthetic semaglutide with Ozempic® for glycemic control. Renal and Urology News, a trusted source of medical news and ...

Samsung's latest S flagships are here: the Galaxy S26 ($899.99), the Galaxy S26+ ($1,099.99), and the Galaxy S26 Ultra ($1,299.99). All three share many features with the outgoing Galaxy S25 line, but ...